2026. Epigenetic Reprogramming in Triple-Negative Breast Cancer: MolecularMechanisms Driving Metastasis and Therapeutic Resistance. Journal of Disease Mechanisms and Genomics (JDMG). 1, 01 (Apr. 2026), 18–26.